Vaccine-preventable infection with congenital risk
Measles cases have risen in England this year, prompting NHS and UKHSA to widen a catch‑up vaccination effort targeting children who missed jabs. Authorities report rising illness despite long‑standing vaccination programs, with campaigns reaching families via GPs, NHS app, and letters. The initiative aims to prevent outbreaks as authorities stress vaccines’ role in protecting vulnerable groups.
Moderna has won FDA approval for its mRNA flu vaccine mFlusiva for adults 50–64 and accelerated approval for those 65 and older. The decision follows a contentious review earlier this year, a unanimous advisory panel recommendation in June and political disputes inside US health agencies over mRNA vaccines. Retail availability is expected in coming weeks.
President Trump has signed an executive order directing federal health officials to cut the federal recommended childhood vaccine list, to split the combined MMR vaccine into separate measles, mumps and rubella doses once single‑disease products are available, and to space routine immunisations across separate medical visits. Public health groups and drugmakers have said the changes lack scientific support and will increase missed vaccinations during a major U.S. measles outbreak.
The White House has issued an executive order reducing federal vaccine recommendations to 11 core shots and urging the separation of the MMR vaccine into three injections. Physicians warn the move risks confusion and slower protection, while public health groups stress that CDC guidance remains unchanged and vaccines should proceed as recommended.
The Trump administration has urged states to separate the measles, mumps and rubella vaccine into individual shots. Several officials caution that doing so could fuel vaccine hesitancy and leave immunity gaps while some leaders push for more personal choice in immunization policies. New reporting shows the policy debate is unfolding amid mixed messages from health agencies and political leaders.
New documents obtained by AP and The Guardian contradict Kennedy's congressional testimony about his 2019 Samoa visit, showing he asked to study MMR vaccines and used